Contents

Current Drug Safety, Volume 1 - Number 2

Evolving Paradigms in Pharmacovigilance

, 1(2): 127 - 134

Wendy Brewster, Trevor Gibbs, Karol LaCroix, Alison Murray, Michael Tydeman and June Almenoff


DOI: 10.2174/157488606776930599




Reducing False Positive Findings in Statistical Analysis of Pharmacogenomic Biomarker Studies Using High-Throughput Technologies

, 1(2): 135 - 141

Shigeyuki Matsui


DOI: 10.2174/157488606776930517




Psychiatric Side Effects of Interferon Treatment

, 1(2): 143 - 150

Scott B. Patten


DOI: 10.2174/157488606776930562




InhaledInsulin: A Novel and Non-Invasive Way for Insulin Administration?

, 1(2): 151 - 158

Teresa Quattrin


DOI: 10.2174/157488606776930526




Exogenous Surfactant in Paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome

, 1(2): 159 - 168

Stephen D. Playfor and Venkata K.T. Nootigattu


DOI: 10.2174/157488606776930553




The Role of the New Zealand Intensive Medicines Monitoring Programme in Identification of Previously Unrecognised Signals of Adverse Drug Reactions

, 1(2): 169 - 178

David W.J. Clark and Mira Harrison-Woolrych


DOI: 10.2174/157488606776930544




Sirolimus Early Graft Nephrotoxicity: Clinical and Experimental Data

, 1(2): 179 - 187

Nicolas Pallet, Eric Thervet, Christophe Legendre and Dany Anglicheau


DOI: 10.2174/157488606776930580




The Safety and Efficacy of Parathyroid Hormone (PTH) as a Biological Response Modifier for the Enhancement of Bone Regeneration

, 1(2): 189 - 203

Christopher C. Tzioupis and Peter V. Giannoudis


DOI: 10.2174/157488606776930571




The Safety of the Temozolomide in Patients with Malignant Glioma

, 1(2): 205 - 222

Alessandro Dario and Giustino Tomei


DOI: 10.2174/157488606776930535




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science